×
About 3,952 results

ALLMedicine™ Focal Segmental Glomerulosclerosis Center

Research & Reviews  1,951 results

Incidence and factors associated with prescribing renin-angiotensin-system inhibitors i...
https://doi.org/10.1111/jch.14224
Journal of Clinical Hypertension (Greenwich, Conn.); Nishiwaki H, Niihata K et. al.

Mar 1st, 2021 - Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are prescribed as conservative or adjunctive therapies for adult idiopathic nephrotic syndrome. However, studies on real-world practice patterns are scarce. ...

Bisphosphonate nephropathy: a case series and review of the literature.
https://doi.org/10.1111/bcp.14780
British Journal of Clinical Pharmacology; de Roij van Zuijdewijn C, van Dorp W et. al.

Feb 17th, 2021 - From rat studies, human case reports and cohort studies, bisphosphonates seem to impair renal function. However, when critically reviewing the literature, zoledronate and pamidronate are more frequently involved in renal deterioration than other b...

see more →

Guidelines  1 results

Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Impr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983378
Kidney International; Swanepoel CR, Atta MG et. al.

Feb 5th, 2018 - HIV-positive individuals are at increased risk for kidney disease, including HIV-associated nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex kidney disease, and comorbid kidney disease, as well as kidney injury resulti...

see more →

Clinicaltrials.gov  1,979 results

Incidence and factors associated with prescribing renin-angiotensin-system inhibitors i...
https://doi.org/10.1111/jch.14224
Journal of Clinical Hypertension (Greenwich, Conn.); Nishiwaki H, Niihata K et. al.

Mar 1st, 2021 - Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are prescribed as conservative or adjunctive therapies for adult idiopathic nephrotic syndrome. However, studies on real-world practice patterns are scarce. ...

Bisphosphonate nephropathy: a case series and review of the literature.
https://doi.org/10.1111/bcp.14780
British Journal of Clinical Pharmacology; de Roij van Zuijdewijn C, van Dorp W et. al.

Feb 17th, 2021 - From rat studies, human case reports and cohort studies, bisphosphonates seem to impair renal function. However, when critically reviewing the literature, zoledronate and pamidronate are more frequently involved in renal deterioration than other b...

see more →

News  17 results

What Causes Focal Segmental Glomerulosclerosis?
https://www.medscape.com/viewarticle/873598

Dec 28th, 2016 - Bone Marrow-Derived Immature Myeloid Cells Are a Main Source of Circulating suPAR Contributing to Proteinuric Kidney Disease Hahm E, Wei C, Fernandez I, et al Nat Med. 2016 Dec 12. [Epub ahead of print] Remember when we first learned that many gas...

Dual-Pathway Inhibitor Targets Glomerular Disease
https://www.medscape.com/viewarticle/872448

Nov 27th, 2016 -   CHICAGO — Sparsentan, which was developed for the treatment of hypertension, is emerging as a targeted therapy for primary focal segmental glomerulosclerosis (FSGS), research from the phase 2 DUET trial suggests. "Primary focal segmental glomeru...

Dual-Pathway Inhibitor Targets Glomerular Disease
https://www.staging.medscape.com/viewarticle/872448

Nov 27th, 2016 -   CHICAGO — Sparsentan, which was developed for the treatment of hypertension, is emerging as a targeted therapy for primary focal segmental glomerulosclerosis (FSGS), research from the phase 2 DUET trial suggests. "Primary focal segmental glomeru...

Blood Factor Linked to Kidney Disease
https://www.medpagetoday.com/nephrology/generalnephrology/35867

Nov 10th, 2012 - Action Points This study analyzed circulating soluble urokinase receptor levels in two cohorts of children and adults with biopsy proven primary focal segmental glomerulosclerosis. The investigators found significantly elevated levels in both grou...

Keeping Lupus Nephritis at Bay: MMF or Azathioprine?
https://www.medscape.com/viewarticle/756432

Jan 5th, 2012 - Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis Dooley MA, Jayne D, Ginzler EM, ALMS Group, et al N Engl J Med. 2011;365:1886-1895 The treatment of lupus nephritis has long been controversial due to a number of factors...

see more →

Patient Education  4 results see all →